Pioglitazone improves insulin sensitivity, reduces visceral fat and stimulates lipolysis in non diabetic dialyzed patients

• Autori principali: Anne Zanchi (Autore), Luc Tappy (Autore), Nicolas Theumann (Autore), Georges Halabi (Autore), Thierry Gauthier (Autore), Claudine Mathieu (Autore), Sylvie Tremblay (Autore), Pauline Coti Michel (Autore), Burnier Daniel Teta (Autore)
• Natura: Libro
• Pubblicazione: The Korean Society of Nephrology, 2012-06-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Insulin resistance is common in dialyzed patients and is associated with increased mortality and protein-energy wasting. The aim of this study was to investigate the effect of pioglitazone (PIO), a powerful insulin sensitizer, on insulin sensitivity, body composition and adipose tissue metabolism, i...